Inventor
HANNA MAZEN
US24 patents
⚠️ This page may combine multiple inventors who share the name “HANNA MAZEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HANNA MAZEN
9 patentsUS9169279B2Oct 27, 2015
Crystallization method and bioavailability
HANNA MAZEN87 citations95
US8399023B2Mar 19, 2013
Crystallization method and bioavailability
HANNA MAZEN94 citations95
US8241371B2Aug 14, 2012
Method of creating crystalline substances
HANNA MAZEN19 citations86
US9340565B2May 17, 2016
Crystalline forms
HANNA MAZEN5 citations82
US8486927B2Jul 16, 2013
Crystalline forms of lamotrigine
HANNA MAZEN3 citations61
US8389512B2Mar 5, 2013
In vivo studies of crystalline forms of meloxicam
HANNA MAZEN2 citations61
US8124603B2Feb 28, 2012
In vivo studies of crystalline forms of meloxicam
HANNA MAZEN4 citations61
US8980868B2Mar 17, 2015
Oral forms of a phosphonic acid derivative
HANNA MAZEN2 citations59
US8586587B2Nov 19, 2013
Crystalline molecular complex of tadalafil and methylparaben
HANNA MAZEN0 citations51
GRUENENTHAL CHEMIE
6 patentsUS10195218B2Feb 5, 2019
Crystallization method and bioavailability
GRUENENTHAL CHEMIE0 citations52
US10526358B2Jan 7, 2020
Crystalline forms
GRUENENTHAL CHEMIE0 citations51
US10519176B2Dec 31, 2019
Crystalline forms
GRUENENTHAL CHEMIE0 citations51
US10323052B2Jun 18, 2019
Crystallization method and bioavailability
GRUENENTHAL CHEMIE0 citations51
US9682091B2Jun 20, 2017
Oral forms of a phosphonic acid derivative
GRUENENTHAL CHEMIE0 citations50
US10093691B2Oct 9, 2018
Crystallization method and bioavailability
GRUENENTHAL CHEMIE0 citations49
THAR PHARMACEUTICALS INC
3 patentsUS8933057B2Jan 13, 2015
Crystallization method and bioavailability
THAR PHARMACEUTICALS INC90 citations96
US9334296B2May 10, 2016
Crystallization method and bioavailability
THAR PHARMACEUTICALS INC4 citations82
US9040535B2May 26, 2015
Crystalline molecular comlpexes of tadalafil
THAR PHARMACEUTICALS INC0 citations50